Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds.
SinglePoint, Inc. (OTC: SING) is a company that has definitely earned its place among the members of the marijuana market.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) was among the very first companies to obtain a cannabis production license in that country and has since been working to change the face of medical cannabis—both in Canada and globally.
SinglePoint, Inc. (OTC: SING) has evolved from a full-service provider of mobile technology to a publicly traded holding company focused on diversifying into horizontal markets that offer multiple revenue streams for investors.
ChineseInvestors.com, Inc. (OTCQB: CIIX), a leading financial information website for Chinese-speaking investors in the United States, China and Canada.
The Canadian government’s plan to push through legalization of marijuana for recreational purposes by mid-2018 figures to deal a serious blow to the existing black market.
PotNetwork Holding, Inc. (OTC: POTN) revenues are projected to reach greater than $30 million by FY2019, $16.7 million in FY2018 and $8.4 million this fiscal year, according to SeeThruEquity, LLC.
Numerous industries are being impacted. Cultivation and medicine are just a couple of examples, but cannabis is showing a strong presence in the retail, consulting, and consumer sectors.
There’s an abundance of scientific evidence proving the medical efficacy of CBD, and investors are flooding the space seeking a share of this colossal 700% growth.
ChineseInvestors.com, Inc. (OTCQB: CIIX) is growing in numerous directions due to its diverse strategy of marketing, communications and product development both within China and to the global Chinese-speaking community.
The CBD market is growing expotentially and consequently the founders of MCOA have contructed their business model around the development of industrial hemp-based CBD products.
For prospective investors, this climb has created an opportunity to capitalize on the most significant evolution of the global currency landscape in decades.
A recent analysis by Eight Capital, a Toronto-based investment bank, targets the potential Canadian international medical cannabis market at a staggering $142 billion over the next 15 years.
In about three months, recreational marijuana sales will kick off in California, yet no one knows exactly how the pot economy will work.
It could take until late November for the state to issue regulations that will govern the new marketplace.
So much marijuana reform, so much time left on the calendar in 2017. Arizona, Connecticut, Hawaii, Kentucky, Maryland, Mississippi, Missouri, New Hampshire, New Jersey, New Mexico, New York, Pennsylvania, Texas, Wyoming, and Washington, D.C. all have strong policymakers working to actively legalize and regulate cannabis. When passed, these 14 states will follow in the footsteps of Alaska, California, Colorado, Maine, Massachusetts, Nevada, Oregon, and Washington.